Datasets:
metadata
title: 'House Oversight: Estate Documents (Nov 12) (HOUSE_OVERSIGHT_020992)'
source: 'House Oversight: Estate Documents (Nov 12)'
sourceUrl: https://www.justice.gov/epstein
date: '2026-01-01'
category: House Oversight
eftaNumber: HOUSE_OVERSIGHT_020992
ocrPages: 1
ocrChars: 2162
ocrElapsed: 0
parseTier: external-legacy
engine: engine undisclosed (ep-nov-12.greg.technology mirror)
externalSource: greg-ep-nov-12
externalLicense: not granted
externalCredit: ep-nov-12.greg.technology
externalUrl: https://ep-nov-12.greg.technology
Restructure Medicare & Medicaid: Economic Factors— Poor Information & Lack of Price Transparency Make it Harder for Consumers to "Comparison Shop" Patients are at a healthcare information disadvantage in two respects: • Lack of transparency: > It's harder for consumers to compare prices of healthcare services from different healthcare providers than in other consumer markets given the complexity of healthcare market. > With employer- / government-subsidized insurance, many patients are 'locked in' with their insurance plans that do not incentivize "shopping around." • Knowledge gap: > Unlike other markets where consumers tend to use their own information and preferences, consumers depend more on the advice and guidance of physicians or other healthcare suppliers. > Unlike other "merchandise," healthcare is literally of life-and-death importance to consumers, making risk aversion - and price insensitivity - higher. This price insensitivity is exacerbated because the consumer, in effect, gets it at a discounted price anyway. Source: 1) Accounting for the cost of US healthcare, McKinsey Global Institute www.kpcb.com USA Inc. | What Might a Turnaround Expert Consider? 301 Restructure Medicare & Medicaid: Economic Factors— Consumers Increasingly Demand Expensive Treatment and Are Able to Pay for it With Government Subsidies Total High-End Surgeries up 50x from 1970-2004, Driven by Medical Advancements + Consumer Ability to Spend Assisted by Government Payments # of Patients (Aged 50+) Undergoing Typical Costs per Advanced Procedures in USA Procedure ($) 1970 2004 Coronary Procedures Angioplasty / Stent Implantation Pacemaker / ICD^ Bypass <20,000 1.1 million $12,000 <10,000 <10,000 Dialysis Procedures <10,000 350,000 220,000 480,000 $15-34,000 $28,000 $24-72,000 per year Joint Replacement Procedures Hip Knee 3 www.kpcb.com <20,000
390,000 $12,500 440,000 $12,500 Note: 1) /CD is Implantable Cardioverter Defibrillator, which is similar to a pacemaker but for a heart rhythm that beats too fast. Cost of procedure approximated by Medicare reimbursement. USA Inc. | What Might a Turnaround Expert Consider? 302 HOUSE _OVERSIGHT_020992